CH578568A5 - - Google Patents

Info

Publication number
CH578568A5
CH578568A5 CH1715072A CH1715072A CH578568A5 CH 578568 A5 CH578568 A5 CH 578568A5 CH 1715072 A CH1715072 A CH 1715072A CH 1715072 A CH1715072 A CH 1715072A CH 578568 A5 CH578568 A5 CH 578568A5
Authority
CH
Switzerland
Application number
CH1715072A
Original Assignee
Lewenstein Evalina
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lewenstein Evalina filed Critical Lewenstein Evalina
Publication of CH578568A5 publication Critical patent/CH578568A5/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/06—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
    • C07D489/08—Oxygen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Addiction (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH1715072A 1971-11-26 1972-11-24 CH578568A5 (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US00202575A US3814768A (en) 1971-11-26 1971-11-26 6-methylene-6-desoxy dihydro morphine and codeine derivatives and pharmaceutically acceptable salts

Publications (1)

Publication Number Publication Date
CH578568A5 true CH578568A5 (xx) 1976-08-13

Family

ID=22750450

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1715072A CH578568A5 (xx) 1971-11-26 1972-11-24

Country Status (7)

Country Link
US (1) US3814768A (xx)
JP (1) JPS5653556B2 (xx)
CA (1) CA974235A (xx)
CH (1) CH578568A5 (xx)
DE (1) DE2257715C2 (xx)
FR (1) FR2160957B1 (xx)
GB (1) GB1411129A (xx)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4322426A (en) * 1980-04-28 1982-03-30 E. I. Du Pont De Nemours And Company 17-Substituted-6-desoxy-7,8-dihydro-6α-methylnoroxymorphone narcotic antagonists
JPS5855258A (ja) * 1981-09-30 1983-04-01 Ricoh Co Ltd 熱転写型カラープリンタ
JPS5889377A (ja) * 1981-11-20 1983-05-27 Canon Inc ドツトプリンタ
US4477457A (en) * 1982-10-28 1984-10-16 E. I. Du Pont De Nemours And Company Method for inducing anorexia using nalmetrene
US4478840A (en) * 1983-10-11 1984-10-23 E. I. Du Pont De Nemours And Company Appetite suppressing compositions and methods
US4535157A (en) * 1983-11-01 1985-08-13 Key Pharmaceuticals, Inc. Process for making 6-desoxy-6-methylenenaloxone and 6-desoxy-6-methylenenaltrexone
US4639455A (en) * 1984-10-02 1987-01-27 Key Pharmaceuticals, Inc. Means of aiding in the prevention of sudden infant death syndrome
US4751307A (en) * 1985-01-17 1988-06-14 Mallinckrodt, Inc. Wittig-reaction processes
WO1987001282A2 (en) * 1985-09-06 1987-03-12 Key Pharmaceuticals, Inc. Method and composition for providing sustained opioid antagonism
US5028612A (en) * 1990-03-22 1991-07-02 Hillel Glover Method for treating emotional numbness
ES2665999T3 (es) * 2002-05-31 2018-04-30 Titan Pharmaceuticals, Inc. Dispositivo polimérico implantable para la liberación sostenida de buprenorfina
PL1610791T3 (pl) 2003-03-31 2011-07-29 Titan Pharmaceuticals Inc Wszczepialne urządzenie polimerowe do przedłużonego uwalniania agonisty dopaminy
EP2317316A3 (en) * 2005-07-08 2011-06-15 Braincells, Inc. Methods for identifying agent and conditions that modulate neurogenesis
CN103012416B (zh) * 2011-09-28 2015-07-01 辽宁海思科制药有限公司 一种盐酸纳美芬的制备方法
TWI560170B (en) * 2011-12-06 2016-12-01 Lundbeck & Co As H Process for recovery of nalmefene hydrochloride
CN102584840A (zh) * 2011-12-28 2012-07-18 南京优科生物医药有限公司 一种制备纳美芬化合物的方法
US20140005217A1 (en) 2012-06-27 2014-01-02 H. Lundbeck A/S Nalmefene for reduction of alcohol consumption in specific target populations
HU231191B1 (hu) 2013-04-15 2021-08-30 Szegedi Tudományegyetem Izotóp tartalmú morfin molekulák
CN103204859B (zh) * 2013-04-25 2015-12-02 四川海思科制药有限公司 一种盐酸纳美芬化合物及其制备方法
SG10201809280PA (en) 2014-04-22 2018-11-29 Otsuka Pharma Co Ltd Combination of brexpiprazole and nalmefene and use thereof for treating substance-related disorders

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3162639A (en) * 1964-12-22 G-desoxy-ix-hydroxy-dihydromorphine

Also Published As

Publication number Publication date
FR2160957B1 (xx) 1975-11-28
FR2160957A1 (xx) 1973-07-06
JPS4858000A (xx) 1973-08-14
CA974235A (en) 1975-09-09
DE2257715A1 (de) 1973-05-30
US3814768A (en) 1974-06-04
GB1411129A (en) 1975-10-22
DE2257715C2 (de) 1985-06-05
JPS5653556B2 (xx) 1981-12-19

Similar Documents

Publication Publication Date Title
FR2160957B1 (xx)
ATA136472A (xx)
AR196074A1 (xx)
AU2658571A (xx)
AU2941471A (xx)
AU2952271A (xx)
AU3005371A (xx)
AU2485671A (xx)
AU2684071A (xx)
AU2684171A (xx)
AU2930871A (xx)
AU1109576A (xx)
AU2399971A (xx)
AU2503871A (xx)
AU2415871A (xx)
AU2455871A (xx)
AU2456871A (xx)
AU2473671A (xx)
AU2927871A (xx)
AU2577671A (xx)
AU2588771A (xx)
AU2654071A (xx)
AU2940971A (xx)
AR202997Q (xx)
AU2486471A (xx)

Legal Events

Date Code Title Description
PUE Assignment

Owner name: PHARMEDIX INTERNATIONAL, LTD

PFA Name/firm changed

Owner name: IVAX PHARMACEUTICALS, INC.

PUE Assignment

Owner name: PHARMEDIX INC.

PUE Assignment

Owner name: BAKER CUMMINS PHARMACEUTICALS, INC.

PL Patent ceased